4|0|Public
40|$|Ro 05 - 9963 in {{the plasma}} and saliva of 10 {{patients}} with malignant disease have been determined. A good linear correlation was established between plasma and saliva misonidazole concentration, and salivary sampling {{was found to}} be suitable for the estimation of a number of pharmacokinetic parameters. Data are also presented for serial tumour concentrations of misonidazole and Ro 05 - 9963 in 3 of the 10 patients. Monitoring of salivary misonidazole concentration appears to be a useful alternative to plasma monitoring, particularly for those patients in whom plasma sampling is unsuitable or impossible. THE HYPOXIC CELL RADIOSENSITIZER, misonidazole (MIS; 1 - (2 - <b>nitroimidazol...</b>|$|E
40|$|Metronidazole (MTZ) and its {{derivatives}} {{have been}} extensively {{used to treat}} infections caused by protozoa and anaerobic bacteria. In this investigation several novel imidazole and <b>nitroimidazol</b> derivatives namely: 2 -(1 H- 1 -imidazolyl) - 1 -phenyl- 1 -ethanol 1 a, 2 -(2 -methyl- 1 H- 1 -imidazolyl) - 1 -phenyl- 1 -ethanol 1 b, 2 -(2 -methyl- 4 -nitro- 1 H- 1 -imidazolyl) - 1 -phenyl- 1 -ethanol 1 c, 2 -(1 H- 1 -imidazolyl) - 1 -cyclohexanol 2 d and 2 -(2 -methyl- 4 -nitro- 1 H- 1 -imidazolyl) - 1 -cyclohexanol 2 e were prepared by {{the reaction of the}} corresponding imidazoles with styrene oxide or cyclohexene oxide respectively and their biological activity against Giardia lamblia cyst in compareison with MTZ were determined by flotation technique based on Bingham method. These compounds were less active than metronidazole but showed significant antigiardiasis activity...|$|E
40|$|Background and Purpose—Nitroimidazole imaging is a {{promising}} contender for noninvasive in vivo mapping of brain hypoxia after stroke. However, {{there is a}} dearth {{of knowledge about the}} behavior of these compounds in the various pathophysiologic situations encountered in ischemic stroke. In this article we report the findings from a systematic review of the literature {{on the use of the}} nitroimidazoles to map hypoxia after stroke. Summary of Review—We describe the characteristics of nitroimidazoles as imaging tracers, their pharmacology, and results of both animal and clinical studies during and after focal cerebral ischemia. Findings in brain tumors are also presented to the extent that they enlighten results in stroke. Early results from application of kinetic modeling for quantitative measurement of tracer binding are briefly discussed. Conclusions—Based on this literature review, nitroimidazole hypoxia imaging agents are of considerable interest in stroke because they appear, both in animal models and in humans, to specifically detect the severely hypoxic viable tissue, but not the reperfused nor the necrotic tissue. To fully realize this potential in stroke, however, formal validation by concurrent measurement of tissue oxygen tension, together with development of novel ligands with faster distribution kinetics, faster clearance from normal tissue, and well-defined trapping mechanisms, are important goals for future investigations. (Stroke. 2008; 39 : 1629 - 1637.) Key Words: imaging ischemia PET stroke hypoxia <b>nitroimidazol...</b>|$|E
40|$|Metoder har utvecklats för att kunna bestämma tolv antibiotikasubstanser, vanliga inom human medicin, i miljöprover. Fokus lades på trimetoprim samt substanser från följande grupper: fluorokinoloner, sulfonamider, penicilliner, cefalosporiner, nitroimidazoler, tetracykliner samt makrolider. Vid extraktion användes fast-fas extraktion för vattenprover och ultraljuds-assisterad fast-fas/vätske extraktion för fasta prover. För separering och bestämning användes vätskekromatografi tandemmasspektrometri. Interna standarder nyttjades för att öka noggrannhet och precision. Extraktionsutbyte låg mellan 50 % och 100 % för vattenfaser och 14 % och 100 % för fasta faser. Koncentrationer och massflöden bestämdes för antibiotikasubstanser i inkommande och utgående vatten och slam, från fem avloppreningsverk i Sverige, samt i avloppsvatten från ett sjukhus. I sjukhusavloppsvattnet så påträffades {{ciprofloxacin}} (en fluorokinolon) och metronidazol (en <b>nitroimidazol)</b> i höga halter (µg/L nivå). Screening-studien vid de fem avloppsreningsverken visade att norfloxacin, ofloxacin, ciprofloxacin och doxycyklin ofta förekom i inkommande och utgående vatten och slam. Trimetoprim och sulfametoxazol påvisades inte i slam men förekom i snarlika koncentrationer i det utgående vattnet relativt det inkommande. I vattenfasen så förekom de sex antibiotikasubstanserna i ng/L nivån och i slam förekom norfloxacin, ofloxacin, ciprofloxacin, och doxycyklin i låga mg/kg nivån. En studie genomfördes där beteendet hos antibiotikasubstanser under avloppsrening studerades. De två fluorokinolonerna, norfloxacin och ciprofloxacin, adsorberade till slam och mindre än 5 % av den totala mängd som kommer till avloppsreningsverket påvisades i det utgående vattnet. I slam var motsvarande andel 70 %. Resultat från en process som värmebehandlar rötat avvattnat slam antyder att cirka 50 % av de två fluorokinolonerna bryts ner. Trimetoprim adsorberade inte till slam och 100 % av total mängd återfanns i det utgående vattnet. Teoretiska beräkningar av koncentrationer och massflöden visade god korrelation till kvantitativa resultat. Ökad noggrannhet i beräkningarna fås genom att beakta stabilitet och fasfördelning. Effekten av antibiotikasubstanser i miljön är idag okänd. Resultat från testprotokoll där deras toxicitet bedöms är i många fall irrelevanta. Tester där organismer är kroniskt exponerade av biologiskt aktiva substanser vid låga koncentrationer är få. Dessutom så fokuserar de ej på de stora potentiella effekterna såsom utveckling eller bevaring av resistenta stammar av bakterier i miljön. Ytterligare studier av förekomst, öde och effekt av antibiotikasubstanser i miljön är nödvändiga. Methods {{were developed}} for determining levels in environmental samples of twelve antibiotics that {{are commonly used}} in human medicine: trimethoprim and substances from the following groups: fluoroquinolones, sulfonamides, penicillins, cephalosporines, nitroimidazoles, tetracyclines and macrolides. These substances were extracted from liquid and solid samples by solid phase extraction and ultrasonic-assisted liquid/solid extraction, respectively. Liquid chromatography tandem mass spectrometry was then used to separate and quantify them, and internal standards were added to improve the accuracy and precision of the determinations. Extraction yields from aqueous and solid phases were in the ranges 50 - 100 % and 14 - 100 %, respectively. Concentrations and mass flows of antibiotic substances were determined in a hospital effluent and in the raw sewage water, final effluent, and sludge from five sewage treatment plants (STPs) scattered across Sweden. High levels (in the µg/L range) of ciprofloxacin (a fluoroquinolone) and metronidazole (a nitroimidazole), {{were found in the}} hospital effluent. The screening study of the five sewage treatment plants revealed that norfloxacin, ofloxacin, ciprofloxacin, and doxycycline were frequently present in the raw sewage water, final effluent and sludge. Trimethoprim and sulfamethoxazole were not detected in the sludge, but these substances were present in the final effluents at concentrations close to those of the raw sewage water. In the aqueous phase, these six antibiotics were present in the ng/L range and in the solid phase, norfloxacin, ofloxacin, ciprofloxacin, and doxycycline were present in the low mg/kg range. The behaviour of the antibiotic substances during sewage water treatment was also investigated in one of the STPs. The two fluoroquinolones, norfloxacin and ciprofloxacin, sorbed to sludge, and less than 5 % of the total amounts that entered the STP were found in the final effluent. In sludge, the corresponding figure was 70 %. Results from a process in which digested dewatered sludge was treated with heat (producing pellets) indicated that approximately 50 % of the two fluoroquinolones had been degraded. Trimethoprim did not sorb to sludge and 100 % of its total amount was found in the final effluent. Theoretical calculations of concentrations and mass flows correlated well with quantitative results for the antibiotics that were frequently detected, but not for the others. In order to increase the accuracy of the calculations, the stability and phase distribution of the antibiotics should be considered. The effects of antibiotics present in the environment are currently unknown. Results of test protocols to assess their toxicity are often irrelevant, and there have been few tests in which organisms have been chronically exposed to biologically active substances at low concentrations. In addition, these tests have not addressed the immense potential of antibiotics in the environment to induce the development of resistant strains of bacteria and to maintain populations of resistant strains. Further studies of the occurrence, fate, and, effects of antibiotic substances in the environment are required...|$|E

